Katerina A. Politi, Ph.D.
Affiliations: | 2003 | Columbia University, New York, NY |
Area:
Genetics, Oncology, Molecular BiologyGoogle:
"Katerina Politi"Parents
Sign in to add mentor| Argiris Efstratiadis | grad student | 2003 | Columbia | |
| (Genetic analysis of mouse tumorigenesis.) | ||||
| Harold Elliot Varmus | post-doc | 2003-2009 | Memorial Sloan-Kettering Cancer Center | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hu B, Wiesehöfer M, de Miguel FJ, et al. (2024) ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer Research |
| Kuhlmann-Hogan A, Cordes T, Xu Z, et al. (2024) EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth. Cancer Discovery. OF1-OF22 |
| Kuhlmann-Hogan A, Cordes T, Xu Z, et al. (2024) EGFR-driven lung adenocarcinomas coopt alveolar macrophage metabolism and function to support EGFR signaling and growth. Cancer Discovery |
| Blair LM, Juan JM, Sebastian L, et al. (2023) Oncogenic context shapes the fitness landscape of tumor suppression. Nature Communications. 14: 6422 |
| Stockhammer P, Grant M, Wurtz A, et al. (2023) Co-occurring Alterations in Multiple Tumor Suppressor Genes are Associated with Worse Outcomes in Patients with EGFR-mutant Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
| de Miguel FJ, Gentile C, Feng WW, et al. (2023) Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer. Cancer Cell |
| Exposito F, Redrado M, Houry M, et al. (2023) PTEN loss confers resistance to anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells. Cancer Research |
| Kuhlmann-Hogan A, Cordes T, Xu Z, et al. (2023) EGFR lung adenocarcinomas coopt alveolar macrophage metabolism and function to support EGFR signaling and growth. Biorxiv : the Preprint Server For Biology |
| Mart Nez-Terroba E, de Miguel FJ, Li V, et al. (2023) Overexpressed Drives Metastasis through Inflammatory Reprogramming of Lung Adenocarcinoma Microenvironment. Biorxiv : the Preprint Server For Biology |
| Grant MJ, Aredo JV, Starrett JH, et al. (2023) Efficacy of osimertinib in patients with lung cancer positive for uncommon EGFR exon 19 deletion mutations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |